FDA lifts bar for Sun at its key Halol plant

Sun Pharma can finally begin to receive US Food and Drug Administration (FDA) approvals for new products from its key Halol formulations manufacturing facility in Gujarat, India, after successfully addressing all issues in a longstanding warning.

More from Manufacturing

More from Business